ACOR - Spark Newswire

2 minute read

Acorda Therapeutics Announces New Agreement With Catalent For Long-Term Global Supply Of INBRIJA

January 5, 5:20 PM

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that on December 31, 2022 it entered into a new long-term global supply agreement with Catalent for the manufacture of INBRIJA (levodopa inhalation powder) at its

ACOR

6 minute read

Acorda Therapeutics Announces Revised Long-Term Financial Guidance

By Benzinga Newsdesk

December 22, 9:04 AM

Key Assumptions Underlying Business Plan and Guidance Remain Unchanged INBRIJA will continue to grow in the U.S. INBRIJA will expand into additional ex-U.S. markets AMPYRA will continue to lose market

ACOR

1 minute read

News

Acorda Therapeutics Receives Nasdaq Listing Determination Letter, Plans To Request Hearing

By Michael Horton

December 20, 6:30 PM

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it was notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC that, due to the Company's common stock not having regained compliance

ACOR

1 minute read

Acorda Therapeutics Announces Passage Of ~2.5:1 Reverse Stock Split Proposal At Special Meeting of Stockholders

By Benzinga Newsdesk

November 11, 10:56 AM

"We are grateful to our shareholders who supported this proposal at a ratio of almost two and a half to one. Authorizing our board to implement a reverse stock split is an important tool, if needed, to ensure that

ACOR

2 minute read

How Is The Market Feeling About Acorda Therapeutics?

By Benzinga Insights

November 9, 4:06 PM

Acorda Therapeutics's (NASDAQ:ACOR) short percent of float has risen 230.3% since its last report. The company recently reported that it has 792 thousand shares sold short, which is 3.27% of all regular shares that are available for trading.

ACOR

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

November 1, 2:10 PM

Gainers

ABMD

5 minute read

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

By Lisa Levin

November 1, 3:31 AM

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.

ACOR

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

October 31, 2:00 PM

Gainers

ACOR

5 minute read

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday

By Lisa Levin

October 28, 4:57 AM

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.

AAN

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

October 27, 1:33 PM

Gainers

ACOR

Feed Symbols: ACOR